Tjalf Ziemssen

74PUBLICATIONS
377CO-AUTHORS
Predictive and prognostic markersHaematologyToxicology (incl. clinical toxicology)SexualitiesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Aug 26, 2026
Distinct Multiomic Signatures of Environmental Exposure Drive Immune Dysregulation and Disease Activity in Early Multiple Sclerosis.

|Aug 19, 2026
Heparin-calibrated anti-factor Xa activity as a surrogate marker for direct oral anticoagulant levels in acute stroke care: a large observational single-center study.

|Jul 16, 2026
The Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis.

|Jun 01, 2026
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

|May 14, 2026
A CSF disease-associated macrophage signature defines progressive multiple sclerosis.

|Apr 23, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Pageof 13

Frequent Collaborators

12 joint publications

Gerd Meyer Zu Horste

10 joint publications

Jan D Lünemann

9 joint publications

Luisa Klotz

8 joint publications

Catharina C Gross